Royalty Report: Medical, Delivery, Device – Collection: 7309

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Medical
  • Delivery
  • Device
  • Disease

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 7309

License Grant
It was set that the Israeli Licensor will transfer to the Licensee, a subsidiary the intellectual property which relates to developing a perishable equipment for insulin pumps.
License Property
The Licensor  has developed the Group’s core technology – the spring-based delivery mechanism. The Licensor operates in conjunction with the Licensee on manufacturing and marketing of the infusion set known by the commercial name SpringTM Universal Infusion Set.

It was also agreed, that the Licensee will sell to the Licensor the products that the Licensor will order from it, in cost prices.

Field of Use
The Field of Use applies to the medical industry.

IPSCIO Record ID: 27452

License Grant
The Licensor hereby grants to the Company the perpetual, fully paid and irrevocable right and license (hereinafter referred to as the 'License') to (I) exclusively (1) manufacture, assemble, produce, sell and distribute to Customers in the Territory, and (2) cause to be manufactured, assembled, produced, sold and distributed to Customers in the Territory by one or more Affiliates or sublicensees of the Company as it may from time to time select, the Pump Components excluding, however, the manufacture, production, or assembly of the Spring Assemblies.

The Company has the exclusive U.S. marketing rights and license for an ambulatory infusion–a round, spring-driven infusion pump with dedicated administration sets and related accessories which also includes an electronic alarm to denote the completion of an infusion.

License Property
SideKick Infusion System — a round, spring-driven infusion pump with dedicated administration sets and related accessories; (ii) the Paragon Infusion System — a round, spring-driven infusion pump with dedicated administration sets and related accessories; and (iii) the Paragon elite Infusion System –a round, spring-driven infusion pump with dedicated administration sets and related accessories which also includes an electronic alarm to denote the completion of an infusion.
Field of Use
The companion product SIDEKICK utilizes a patented spring technology to deliver IV antibiotics over a shorter time period.

IPSCIO Record ID: 7800

License Grant
The Israel Licensor hereby irrevocably assigns and transfers to the Israel Licensee in Formation all rights in the Application for Patent Registration and the Disposal Equipment.
License Property
The Licensor is the owner of rights in the application for a patent registration number US 60/917,075 or any other right in connection with disposable equipment for insulin pumps.
Field of Use
The Licensee wishes to form a company that will receive the rights in the Application for Patent Registration and which shall act in developing, marketing, selling and/or any other act in connection with the Disposal Equipment.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.